COM:GALECTINTHERAPEUTICS
Galectin Therapeutics
- Stock
Last Close
2.72
22/11 21:00
Market Cap
145.43M
Beta: -
Volume Today
132.79K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 579.50K - | 834K 43.92% | 677K 18.82% | 679K 0.30% | 759K 11.78% | 452.50K 40.38% | 979K 116.35% | 1.48M 50.82% | 1.55M 4.88% | 2.85M 83.89% | 5.16M 81.23% | |
average receivables | ||||||||||||
book value per share | 0.49 - | 0.97 98.97% | 1.04 7.05% | 0.41 60.40% | 0.03 91.83% | 0.18 421.10% | 0.87 398.72% | 0.52 40.53% | 0.02 97.06% | -0.57 3,842.84% | -1.00 75.35% | |
capex per share | -0.00 - | |||||||||||
capex to depreciation | -0.42 - | |||||||||||
capex to operating cash flow | 0.00 - | |||||||||||
capex to revenue | ||||||||||||
cash per share | 0.62 - | 1.33 114.47% | 1.07 19.62% | 0.53 50.93% | 0.09 83.65% | 0.21 143.62% | 0.91 334.07% | 0.48 47.64% | 0.68 42.34% | 0.31 53.79% | 0.43 36.25% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 71.13K - | |||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.00 - | 0.00 84.73% | 0.69 46,632.41% | 1.87 169.63% | 2.55 35.91% | |||||||
debt to equity | 0.00 - | 0.00 73.79% | 32.54 2,188,787.31% | -1.18 103.61% | -1.19 1.38% | |||||||
dividend yield | 0.01 - | 0.01 73.75% | 0.02 91.66% | 0.03 8.58% | 0.01 59.88% | 0.01 34.82% | 0.00 61.04% | 0.00 59.33% | 0.00 31.61% | 0.00 2.40% | 0.00 16.86% | |
earnings yield | -0.09 - | -0.21 134.88% | -0.51 143.12% | -0.75 47.91% | -0.14 81.73% | -0.10 24.86% | -0.09 12.89% | -0.18 105.53% | -0.26 38.89% | -0.58 128.46% | -0.41 29.60% | |
enterprise value | 125.85M - | 46.69M 62.90% | 13.71M 70.63% | 13.26M 3.26% | 115.59M 771.45% | 126.94M 9.82% | 101.96M 19.68% | 100.65M 1.29% | 110.56M 9.85% | 88.39M 20.05% | 146.01M 65.19% | |
enterprise value over ebitda | -10.42 - | -3.03 70.97% | -0.68 77.42% | -0.62 9.58% | -7.13 1,053.58% | -9.36 31.34% | -7.74 17.29% | -4.31 44.38% | -3.66 14.90% | -2.31 37.01% | -3.84 66.33% | |
ev to operating cash flow | -16.82 - | -3.76 77.66% | -0.81 78.51% | -0.81 0.12% | -7.27 799.80% | -12.47 71.46% | -9.40 24.63% | -4.89 48.02% | -4.55 6.90% | -2.85 37.42% | -4.43 55.63% | |
ev to sales | ||||||||||||
free cash flow per share | -0.44 - | -0.57 28.14% | -0.70 23.80% | -0.56 20.23% | -0.45 20.34% | -0.26 42.28% | -0.21 19.59% | -0.36 73.95% | -0.42 14.97% | -0.52 25.90% | -0.55 4.79% | |
free cash flow yield | -0.05 - | -0.16 198.38% | -0.43 161.95% | -0.57 33.52% | -0.13 76.63% | -0.08 43.79% | -0.07 3.56% | -0.16 122.10% | -0.20 24.42% | -0.46 130.63% | -0.33 28.67% | |
graham net net | 0.47 - | 0.94 99.24% | 1.02 7.43% | 0.40 60.95% | 0.00 99.40% | 0.16 6,415.35% | 0.85 447.72% | 0.38 55.37% | -0.02 105.77% | -0.62 2,705.40% | -1.04 69.30% | |
graham number | 2.80 - | 3.97 41.67% | 4.40 10.91% | 2.61 40.84% | 0.59 77.44% | 1.18 100.52% | 2.24 90.33% | 2.19 2.16% | 0.43 80.58% | 2.91 583.21% | 3.92 34.67% | |
income quality | 0.62 - | 0.79 27.12% | 0.85 7.74% | 0.77 9.73% | 0.98 27.88% | 0.73 25.19% | 0.82 11.43% | 0.88 7.59% | 0.80 9.30% | 0.80 0.58% | 0.80 0.23% | |
intangibles to total assets | 0.00 - | 0.00 76.46% | 0.00 40.06% | 0.00 79.10% | 0 100% | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -1.35K - | -40.48 97.01% | -154.46 281.55% | -269.47 74.46% | -61.72 77.10% | -37.13 39.84% | 13.64 136.73% | |||||
interest debt per share | 0.00 - | 0.01 2,423.44% | 0.00 71.71% | 0.00 4.77% | 0.50 21,876.18% | 0.69 36.42% | 1.15 66.53% | |||||
inventory turnover | ||||||||||||
invested capital | 0.00 - | 0.00 73.79% | 32.54 2,188,787.31% | -1.18 103.61% | -1.19 1.38% | |||||||
market cap | 136.34M - | 75.82M 44.39% | 39.56M 47.83% | 28.63M 27.63% | 118.64M 314.45% | 135.19M 13.95% | 149.40M 10.51% | 127.74M 14.50% | 121.15M 5.16% | 67.11M 44.60% | 99.86M 48.80% | |
net current asset value | 8.20M - | 21.18M 158.25% | 25.04M 18.23% | 12.01M 52.02% | 851K 92.92% | 6.72M 690.13% | 45.34M 574.26% | 24.06M 46.94% | 886K 96.32% | -34.65M 4,010.84% | -60.73M 75.27% | |
net debt to ebitda | 0.87 - | 1.89 117.34% | 1.29 31.79% | 0.72 44.44% | 0.19 73.69% | 0.61 223.30% | 3.60 491.94% | 1.16 67.82% | 0.35 69.72% | -0.56 258.26% | -1.21 118.39% | |
net income per share | -0.72 - | -0.72 0.87% | -0.83 14.91% | -0.73 11.63% | -0.46 37.71% | -0.35 22.84% | -0.26 27.37% | -0.41 60.98% | -0.53 28.35% | -0.66 24.71% | -0.68 3.42% | |
operating cash flow per share | -0.44 - | -0.57 28.23% | -0.70 23.80% | -0.56 20.23% | -0.45 20.34% | -0.26 42.28% | -0.21 19.59% | -0.36 73.95% | -0.42 14.97% | -0.52 25.90% | -0.55 4.79% | |
payables turnover | 0.01 - | |||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -1.13 - | -0.53 52.93% | -0.76 42.52% | -1.36 78.91% | -3.90 187.48% | -1.54 60.44% | -0.28 82.11% | -0.79 187.76% | -0.74 6.79% | -1.84 148.69% | -1.46 20.93% | |
revenue per share | ||||||||||||
roe | -1.47 - | -0.74 49.30% | -0.80 7.34% | -1.78 123.14% | -13.61 662.77% | -2.02 85.19% | -0.29 85.44% | -0.79 170.71% | -34.69 4,266.04% | 1.16 103.33% | 0.68 41.02% | |
roic | -1.47 - | -0.73 50.75% | -0.80 10.48% | -1.79 123.03% | -13.64 662.86% | -1.97 85.54% | -0.30 84.98% | -0.79 167.23% | -1.02 29.16% | -6.47 533.11% | -3.29 49.14% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | 0.49 - | 0.97 98.97% | 1.04 7.05% | 0.41 60.40% | 0.03 91.83% | 0.18 421.10% | 0.87 398.72% | 0.52 40.53% | 0.02 97.06% | -0.57 3,842.84% | -1.00 75.35% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 8.20M - | 21.18M 158.17% | 25.04M 18.22% | 12.01M 52.02% | 1.19M 90.07% | 6.90M 478.21% | 45.59M 560.99% | 24.19M 46.94% | 893K 96.31% | -33.92M 3,898.10% | -60.24M 77.61% | |
tangible book value per share | 0.49 - | 0.97 99.38% | 1.04 7.09% | 0.41 60.39% | 0.03 91.83% | 0.18 421.10% | 0.87 398.72% | 0.42 51.40% | 0.02 96.40% | -0.57 3,842.84% | -1.00 75.35% | |
working capital | 8.20M - | 27.96M 240.91% | 25.04M 10.44% | 12.01M 52.02% | 851K 92.92% | 6.72M 690.13% | 45.39M 575.03% | 24.07M 46.98% | 32.79M 36.24% | 7.54M 77.00% | 12.03M 59.60% |
All numbers in USD (except ratios and percentages)